9:30 am
Check-in
10:00 am
Welcome
10:15 am
Session I
Navigating the bridge from lab to clinic in stem cell-based therapies
Keynote
Thomas Hassing Ronøe Carlsen (Novo Nordisk, Denmark)
Optimising efficacy of tumor-specific T cells and manufacturing scalability
Keynote
Felix Lorenz (Captain T Cell, Germany)
t.b.a.
Keynote
Karl-Johan Malmberg (University of Oslo, Norway)
11:45 am
Break
12:00 pm
Industry session
12:45 pm
Break
1:30 pm
Industry session
2:15 pm
Break
2:30 pm
Session II
Reprogramming the tumor microenviroment toward immune activation by targeted gene-based cytokine delivery
Keynote
Luigi Naldini (Vita-Salute San Raffaele University, Italy)
Fantastic parvoviral gene therapy vectors and how to find them
Keynote
Dirk Grimm (University of Heidelberg, Germany)
4:00 pm
Poster session I
5:00 pm
Session III
t.b.a.
Keynote
Angela Vollstedt (Novartis, Austria)
The evolving field of cellular therapy in LBCL
Keynote
Anna Sureda (Catalan Institute of Oncology, Spain)
6:30 pm
Get-together
9:00 am
Industry session
9:45 am
Break
10:00 am
Session IV
Role of microbiome for response to chemotherapy and immunotherapy in gastrointestinal cancers
Keynote
Joseph Tintelnot (Universitätsklinikum Hamburg-Eppendorf, Germany)
t.b.a.
Keynote
Florence Renaud (Sorbonne University, France)
11:30 am
Break
11:45 am
Industry session
12:30 pm
Break
1:15 pm
Poster session II
2:15 pm
Session V
In vivo CAR T cells have reached the clinical stage
Keynote
Christian Buchholz (Paul Ehrlich Institut, Germany)
Karolinska ATMP Center & future manufacturing for in vivo CAR T cell therapies
Keynote
Knut Steffensen (Karolinska Institutet, Sweden)
Keynote
Stephan Mielke (Karolinska Institutet, Sweden)
